Advani SD, North R, Turner NA, Ahmadi S, Denniss J, Francis A, et al. Performance of Urinalysis Parameters in Predicting Urinary Tract Infection: Does One Size Fit all? Clin Infect Dis 2024. https://www.ncbi.nlm.nih.gov/pubmed/38666412
Bent S, Saint S. The optimal use of diagnostic testing in women with acute uncomplicated cystitis. Am J Med 2002;113 Suppl 1A:20S-8S. https://www.ncbi.nlm.nih.gov/pubmed/12113868
Bonkat G, Bartoletti R, Bruyère F, Cai T, Geerlings SE, Köves B, et al. EAU Guidelines on Urological Infections. Arnhem, NL: European Association of Urology; 2024. https://uroweb.org/guidelines/urological-infections
Bouiller K, Zayet S, Lalloz PE, Potron A, Gendrin V, Chirouze C, et al. Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales. Antibiotics (Basel) 2022;11(2). https://www.ncbi.nlm.nih.gov/pubmed/35203801
Cai T, Tamanini I, Tascini C, Koves B, Bonkat G, Gacci M, et al. Fosfomycin Trometamol versus Comparator Antibiotics for the Treatment of Acute Uncomplicated Urinary Tract Infections in Women: A Systematic Review and Meta-Analysis. J Urol 2020;203(3):570-8. https://www.ncbi.nlm.nih.gov/pubmed/31651226
Cardoso T, Ribeiro O, Aragao IC, Costa-Pereira A, Sarmento AE. Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study. BMC Infect Dis 2012;12:375. https://www.ncbi.nlm.nih.gov/pubmed/23267668
Carey MR, Vaughn VM, Mann J, Townsend W, Chopra V, Patel PK. Is Non-Steroidal Anti-Inflammatory Therapy Non-Inferior to Antibiotic Therapy in Uncomplicated Urinary Tract Infections: a Systematic Review. J Gen Intern Med 2020;35(6):1821-9. https://www.ncbi.nlm.nih.gov/pubmed/32270403
Cunha BA, Cunha CB, Lam B, Giuga J, Chin J, Zafonte VF, et al. Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications. Eur J Clin Microbiol Infect Dis 2017;36(7):1213-6. https://www.ncbi.nlm.nih.gov/pubmed/28155015
Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med 2013;173(1):62-8. https://pubmed.ncbi.nlm.nih.gov/23212273/
Gágyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ 2015;351:h6544. https://pubmed.ncbi.nlm.nih.gov/26698878/
Geerts AF, Eppenga WL, Heerdink R, Derijks HJ, Wensing MJ, Egberts TC, et al. Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care. Eur J Clin Pharmacol 2013;69(9):1701-7. https://www.ncbi.nlm.nih.gov/pubmed/23660771
Grigoryan L, Trautner BW, Gupta K. Diagnosis and management of urinary tract infections in the outpatient setting: a review. JAMA 2014;312(16):1677-84. https://www.ncbi.nlm.nih.gov/pubmed/25335150
Hoffmann T, Peiris R, Mar CD, Cleo G, Glasziou P. Natural history of uncomplicated urinary tract infection without antibiotics: a systematic review. Br J Gen Pract 2020;70(699):e714-e22. https://www.ncbi.nlm.nih.gov/pubmed/32958533
Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, et al. Effect of 5-day nitrofurantoin vs single-dose fosfomycin on clinical resolution of uncomplicated lower urinary tract infection in women: A randomized clinical trial. JAMA 2018;319(17):1781-9. https://www.ncbi.nlm.nih.gov/pubmed/29710295
Jansaker F, Boel JB, Thonnings S, Hertz FB, Hansen KH, Frimodt-Moller N, et al. Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study. Infect Drug Resist 2019;12:1691-702. https://www.ncbi.nlm.nih.gov/pubmed/31354318
Jansaker F, Li X, Vik I, Frimodt-Moller N, Knudsen JD, Sundquist K. The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study. Antibiotics (Basel) 2022;11(12). https://www.ncbi.nlm.nih.gov/pubmed/36551352
Kronenberg A, Butikofer L, Odutayo A, Muhlemann K, da Costa BR, Battaglia M, et al. Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial. BMJ 2017;359:j4784. https://www.ncbi.nlm.nih.gov/pubmed/29113968
Kwok M, McGeorge S, Mayer-Coverdale J, Graves B, Paterson DL, Harris PNA, et al. Guideline of guidelines: management of recurrent urinary tract infections in women. BJU Int 2022;130 Suppl 3(Suppl 3):11-22. https://www.ncbi.nlm.nih.gov/pubmed/35579121
National Institute for Health and Care Excellence (NICE). Urinary tract infection (lower): antimicrobial prescribing [NG109]. London: NICE; October 2018. https://www.nice.org.uk/guidance/ng109
Nelson Z, Tarik Aslan A, Beahm NP, Blyth M, Cappiello M, Casaus D, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open 2024;7(11):e2444495. https://www.ncbi.nlm.nih.gov/pubmed/39495518
O'Kane DB, Dave SK, Gore N, Patel F, Hoffmann TC, Trill JL, et al. Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women. Cochrane Database Syst Rev 2016;(4):CD010745. https://pubmed.ncbi.nlm.nih.gov/27090883/
Santos JM, Batech M, Pelter MA, Deamer RL. Evaluation of the Risk of Nitrofurantoin Lung Injury and Its Efficacy in Diminished Kidney Function in Older Adults in a Large Integrated Healthcare System: A Matched Cohort Study. J Am Geriatr Soc 2016;64(4):798-805. https://www.ncbi.nlm.nih.gov/pubmed/27100576
Shafrir A, Oster Y, Shauly-Aharonov M, Strahilevitz J. Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women. Biomedicines 2023;11(4). https://www.ncbi.nlm.nih.gov/pubmed/37189635
Singh N, Gandhi S, McArthur E, Moist L, Jain AK, Liu AR, et al. Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women. CMAJ 2015;187(9):648-56. https://www.ncbi.nlm.nih.gov/pubmed/25918178
Ten Doesschate T. 'The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function' - Author's reply. Clin Microbiol Infect 2020;26(10):1422. https://www.ncbi.nlm.nih.gov/pubmed/32305670
Tutone M, Bjerklund Johansen TE, Cai T, Mushtaq S, Livermore DM. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study. Int J Antimicrob Agents 2022;59(5):106574. https://www.ncbi.nlm.nih.gov/pubmed/35307561
Wagenlehner F, Nicolle L, Bartoletti R, Gales AC, Grigoryan L, Huang H, et al. A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance. J Glob Antimicrob Resist 2022;28:18-29. https://www.ncbi.nlm.nih.gov/pubmed/34896337
Wang T, Wu G, Wang J, Cui Y, Ma J, Zhu Z, et al. Comparison of single-dose fosfomycin tromethamine and other antibiotics for lower uncomplicated urinary tract infection in women and asymptomatic bacteriuria in pregnant women: A systematic review and meta-analysis. Int J Antimicrob Agents 2020;56(1):106018. https://www.ncbi.nlm.nih.gov/pubmed/32417205
Yetsko A, Draper HM, Eid K, Jameson AP, Dumkow LE. Two Times Versus Four Times Daily Cephalexin Dosing for the Treatment of Uncomplicated Urinary Tract Infections in Females. Open Forum Infect Dis 2023;10(9):ofad430. https://www.ncbi.nlm.nih.gov/pubmed/37779597
